Inhaled Pentamidine For Pneumocystis jiroveci Prophylaxis in a Heart Transplant Recipient With Allergy for Trimethoprim Sulfamethoxazole
| dc.contributor.author | Altıntaş, Garip | |
| dc.contributor.author | Küçüker, Seref Alp | |
| dc.contributor.author | Hanedan, Onur | |
| dc.contributor.author | Diken, Özlem Erçen | |
| dc.contributor.author | Diken, Adem İlkay | |
| dc.date.accessioned | 2026-04-01T07:52:06Z | |
| dc.date.issued | 2011-02 | |
| dc.description.abstract | Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprim-sulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole. | |
| dc.identifier.citation | Experimental and Clinical Transplantation, Cilt, 9, Sayı, 1, 2011 ss. 72-74 | en |
| dc.identifier.eissn | 2146-8427 | en |
| dc.identifier.issn | 1304-0855 | |
| dc.identifier.issue | 1 | en |
| dc.identifier.uri | https://hdl.handle.net/11727/14698 | |
| dc.identifier.volume | 9 | en |
| dc.language.iso | en | |
| dc.publisher | Başkent Üniversitesi | |
| dc.source | Experimental and Clinical Transplantation | en |
| dc.subject | Pentamidine | |
| dc.subject | Heart transplantation | |
| dc.subject | Pneumocystis carinii | |
| dc.subject | Pneumocystis jiroveci | |
| dc.title | Inhaled Pentamidine For Pneumocystis jiroveci Prophylaxis in a Heart Transplant Recipient With Allergy for Trimethoprim Sulfamethoxazole | |
| dc.type | Case Report |